Why the study?
Does the geko™ electro-stimulation device prevent VTE and provide cost savings in patients at high risk of VTE where other prophylaxis methods are impractical or contraindicated?
Population
People with a high risk of venous thromboembolism and when other mechanical/pharmacological methods of…
Comparison
geko™ single-use, battery-powered, neuromuscular… vs 'no prophylaxis' strategy
Design
Guideline
Authors
Loading...
Supports geko™ adoption for VTE prophylaxis where standard methods are contraindicated; extends cost-effectiveness evidence for neuromuscular stimulation in guidelines.
Does the geko™ electro-stimulation device prevent VTE and provide cost savings in patients at high risk of VTE where other prophylaxis methods are impractical or contraindicated?
NICE recommends the geko™ electro-stimulation device for VTE prophylaxis in high-risk patients where standard methods are impractical or contraindicated, estimating cost savings of £197 per patient.
Summers et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: